Intellus Advisors LLC Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Intellus Advisors LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 1,628 shares of the healthcare conglomerate's stock, valued at approximately $824,000.

Several other institutional investors have also recently added to or reduced their stakes in UNH. Raymond James Financial Inc. acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $1,914,740,000. Amundi boosted its holdings in UnitedHealth Group by 97.2% in the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after purchasing an additional 2,991,470 shares during the period. Proficio Capital Partners LLC raised its position in UnitedHealth Group by 76,830.4% in the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock valued at $955,388,000 after purchasing an additional 1,886,186 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec increased its stake in shares of UnitedHealth Group by 129.7% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate's stock worth $601,951,000 after buying an additional 581,324 shares during the period. Finally, State Street Corp lifted its stake in UnitedHealth Group by 1.3% in the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock worth $26,626,387,000 after acquiring an additional 563,554 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on UNH shares. Oppenheimer increased their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a report on Friday, December 6th. Piper Sandler decreased their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research note on Thursday, January 2nd. Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Cantor Fitzgerald reiterated an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $629.32.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the company's stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.33% of the stock is owned by insiders.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded up $4.67 during midday trading on Wednesday, hitting $518.10. The company had a trading volume of 3,253,715 shares, compared to its average volume of 4,086,604. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $473.92 billion, a price-to-earnings ratio of 33.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The business has a 50-day simple moving average of $509.10 and a two-hundred day simple moving average of $545.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the business earned $5.83 earnings per share. UnitedHealth Group's quarterly revenue was up 6.8% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. UnitedHealth Group's dividend payout ratio is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.